This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.
Latest papers
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITH
Journal of Allergy and Clinical Immunology: In Practice · 2025
Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study.
Journal of asthma and allergy · 2024
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE).
The World Allergy Organization journal · 2023
Latest funding
- $200,000
vACcine COnfidence amongst those living with alleRgy during the coviD pandemic (ACCORD): an integrated knowledge translation study
CIHR · 2021 · Co-investigator
- $267,750
A 15 months, double-Blind, randomized controlled trial comparing 18 weeks of two doses of Omalizumab to placebo to accelerate a symptom-driven Oral immunotherapy schedule in subjects aged 6 to 25 years with Multiple food allergies (BOOM).
CIHR · 2019 · Nominated PI
- $100,000
Childhood cancer and immune dysregulation in siblings
CIHR · 2019 · Co-investigator
10 publications.
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITH
Rodríguez Del Río P, Riggioni C, Deschildre A, Greenhawt M, Schnadt S, Arasi S, Nowak-Wegrzyn A, Wasserman RL, Begin P, Waserman S
Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study.
Guilbert TW, Tolcachier A, Fiocchi AG, Katelaris CH, Phipatanakul W, Begin P, de Mir I, Altincatal A, Gall R, Ledanois O, Radwan A, Jacob-Nara JA, Deniz Y, Rowe PJ
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE).
Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner PJ, Shinder SB, Gupta R, Eigenmann P, Nowak-Wegrzyn A, Ansotegui IJ, Rivas MF, Petrou S, Tanno LK, Vazquez-Ortiz M, Vickery B, Wong G, Alvaro-Lozano M, Asaria M, Begin P, Bozzola M, Boyle R, Brough H, Cardona V, Chinthrajah RS, Cianferoni A, Deschildre A, Fleischer D, Gazzani F, Gerdts J, Giannetti M, Greenhawt M, Guzmán MA, Hossny E, Kauppi P, Jones C, Lucidi F, Monge Ortega OP, Munblit D, Muraro A, Pajno G, Podestà M, Rodriguez Del Rio P, Said M, Santos A, Shaker M, Szajewska H, Venter C, Warren C, Winders T, Ebisawa M, Fiocchi A
An overview of current clinical practice and international oral immunotherapy guidelines: A focus on Spanish, European, and Canadian guidelines.
Frugier C, Begin P
Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: A systematic review and meta-analysis.
de Silva D, Rodríguez Del Río P, de Jong NW, Khaleva E, Singh C, Nowak-Wegrzyn A, Muraro A, Begin P, Pajno G, Fiocchi A, Sanchez A, Jones C, Nilsson C, Bindslev-Jensen C, Wong G, Sampson H, Beyer K, Marchisotto MJ, Fernandez Rivas M, Meyer R, Lau S, Nurmatov U, Roberts G, GA2LEN Food Allergy Guidelines Group
An Approach to the Office-Based Practice of Food Oral Immunotherapy
Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, Greenhawt M, Hare N, Mack DP, Mansfield L
Evaluation of Adverse Reactions to Vaccines.
Des Roches A, Graham F, Begin P, Paradis L, Gold M
Peanut consumption habits and incidence of new peanut allergy in a cohort of younger siblings of peanut-allergic children.
Paquin M, Paradis L, Graham F, Begin P, Des Roches A
Early introduction without screening is a good deal, if caregivers will buy it.
Upton JEM, Poder TG, Begin P
Images in clinical medicine. Familial primary cryofibrinogenemia.
Begin P, Leclerc G
vACcine COnfidence amongst those living with alleRgy during the coviD pandemic (ACCORD): an integrated knowledge translation study
Principal investigators: Protudjer, Jennifer L; Ladouceur, Erika
Keywords: Allergy; Covid-19; Integrated Knowledge Translation; Vaccine Confidence
A 15 months, double-Blind, randomized controlled trial comparing 18 weeks of two doses of Omalizumab to placebo to accelerate a symptom-driven Oral immunotherapy schedule in subjects aged 6 to 25 years with Multiple food allergies (BOOM).
Principal investigators: Bégin, Philippe
Keywords: Food Allergy; Omalizumab; Oral Immunotherapy
Childhood cancer and immune dysregulation in siblings
Principal investigators: Auger, Nathalie
Keywords: Allergy; Asthma; Autoimmune Disease; Childhood Cancer; Cohort Study; Immunomodulation; Longitudinal Data; Siblings
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Susan Waserman and Moshe Ben-Shoshan: 11 shared papers
- Susan Waserman and Douglas Mack: 5 shared papers
- Douglas Mack and Moshe Ben-Shoshan: 2 shared papers
- Douglas Mack and Philippe Bégin: 2 shared papers
- Susan Waserman and Philippe Bégin: 1 shared paper
- Susan Waserman and Carmen Riggioni: 1 shared paper
- Douglas Mack and Carmen Riggioni: 1 shared paper
- Moshe Ben-Shoshan and Philippe Bégin: 1 shared paper
- Philippe Bégin and Carmen Riggioni: 1 shared paper
- Pediatrics
- Allergy and Clinical Immunology
- Medicine
- Other
Co-authors at Université de Montréal, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.